Pacira Biosciences Inc
NASDAQ:PCRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pacira Biosciences Inc
NASDAQ:PCRX
|
US |
|
O
|
Optomed Oyj
OMXH:OPTOMED
|
FI |
|
Sichuan Chuantou Energy Co Ltd
SSE:600674
|
CN |
|
Crocs Inc
NASDAQ:CROX
|
US |
|
H
|
Henkel AG & Co KGaA
DUS:HEN
|
DE |
|
A
|
Atlas Copco AB
SWB:ACO4
|
SE |
|
H
|
Hisense Home Appliances Group Co Ltd
XMUN:GKE
|
CN |
|
C
|
Comstock Inc
AMEX:LODE
|
US |
|
E
|
eBay Inc
XHAM:EBA
|
US |
|
3
|
3M Co
XETRA:MMM
|
US |
|
Reckitt Benckiser Group PLC
LSE:RKT
|
UK |
|
C
|
Ctac NV
F:TAC
|
NL |
|
S
|
SoftBank Group Corp
XMUN:SFT
|
JP |
|
P
|
Paychex Inc
XHAM:PCX
|
US |
|
Mitsui O.S.K. Lines Ltd
TSE:9104
|
JP |
|
A
|
Atlas Copco AB
XBER:ACO2
|
SE |
|
I
|
Industria de Diseno Textil SA
MIL:ITX
|
ES |
Wall St Price Targets
PCRX Price Targets Summary
Pacira Biosciences Inc
According to Wall Street analysts, the average 1-year price target for PCRX is 30.26 USD with a low forecast of 23.23 USD and a high forecast of 39.9 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PCRX's stock price target?
Price Target
30.26
USD
According to Wall Street analysts, the average 1-year price target for PCRX is 30.26 USD with a low forecast of 23.23 USD and a high forecast of 39.9 USD.
What is the Revenue forecast for Pacira Biosciences Inc?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 7 years is 6%.
What is the Gross Profit forecast for Pacira Biosciences Inc?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 41%. The projected CAGR for the next 3 years is 11%.
What is the Operating Income forecast for Pacira Biosciences Inc?
Projected CAGR
50%
The compound annual growth rate for Operating Income over the next 5 years is 50%.
What is the Pre-Tax Income forecast for Pacira Biosciences Inc?
Projected CAGR
163%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 163%.
What is the Net Income forecast for Pacira Biosciences Inc?
Projected CAGR
64%
The compound annual growth rate for Net Income over the next 7 years is 64%.
